Leadership Team

Deep knowledge in advancing drug development.

Our team is comprised of world-class scientific advisors, clinicians and innovation leaders. They have the strategic ability to put key pieces in place for driving clinical development forward.

Executive Team

Jerome D. Jabbour

Chief Executive Officer

Keith A. Kucinski, CPA, MBA

Chief Financial Officer

Board of Directors

Eric J. Ende, M.D., M.B.A

Chairman of the Board

Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A.

Director

Board Committees

Independent Directors	Audit	Compensation	Nominating and Corporate Governance
Eric J. Ende, M.D., M.B.A		Compensation	Nominating and Corporate Governance
Evelyn D’An	Audit		Nominating and Corporate Governance
Natasha Giordano	Audit		Nominating and Corporate Governance
Robin L. Smith, MD, MBA	Audit		Nominating and Corporate Governance
Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A.		Compensation

Chair

Member

Scientific Advisory Board

Infectious Disease Experts - MAT2203

Prof. Oliver Cornely, M.D., FACP, FIDSA

Professor of Internal Medicine and Attending Physician, Uniklinik Köln

Dimitrios P. Kontoyiannis, M.D., M.S., Sc.D., PhD (Hon),FACP, FIDSA, FECMM

Professor in the Department of Infectious Diseases Infection Control and Employee Health, The University of Texas

Peter G. Pappas, M.D., FACP

Professor of Medicine, University of Alabama

David S. Perlin, Ph.D.

Executive Director, New Jersey Medical School (NJMS), Rutgers Biomedical and Health Sciences

Leadership Team

Deep knowledge in advancing drug development.

Executive Team

Jerome D. Jabbour

Keith A. Kucinski, CPA, MBA

Board of Directors

Eric J. Ende, M.D., M.B.A

Jerome D. Jabbour

Evelyn D’An

Natasha Giordano

Robin L. Smith, MD, MBA

Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A.